Nuvation Bio Inc - Ordinary Shares - Class A

NYSE:NUVB   3:59:59 PM EDT
5.61
+0.26 (+4.86%)
Products

Nuvation Bio Announces FDA Clearance Of IND Application For NUV-422 for the Treatment of Advanced Breast Cancer

Published: 12/08/2021 12:19 GMT
Nuvation Bio Inc - Ordinary Shares - Class A (NUVB) - Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for Nuv-422 for the Treatment of Advanced Breast Cancer.
Nuvation Bio Inc - Continuing to Enroll Patients in Phase 1 Dose Escalation Portion of Study.
Nuvation Bio Inc - Look Forward to Sharing Data From Phase 1 Dose Escalation Portion for Nuv-422 in Second Half of 2022.